DCT
1:21-md-03017
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
General
Filed
12/10/21
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
PACER
1:21-md-03017
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
11/01/23 - now | 36% | |
10/04/23 - 11/01/23 | -- | |
12/28/21 - 10/04/23 | 36% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L4 A | |
L5 B | |
L3 B | |
-- -- -- | |
-- -- -- | |
Robinson MillerLocal | L3 B |
L3 E | |
L3 C | |
L5 A | |
L4 A | |
L2 C | |
L1 B | |
L1 D | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L4 E | |
L4 E | |
L4 E | |
L4 E | |
L4 E | |
L3 E | |
L2 E | |
L2 E | |
L2 E | |
L1 D | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L4 B | |
L5 A | |
L5 A | |
L5 A | |
L5 E | |
L4 B | |
L3 E | |
Shaw Keller LLPLocal | L4 D |
L4 D | |
L4 E | |
L4 B | |
L2 A | |
L4 E | |
L2 E | |
L2 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
Morris James LLPLocal | L4 E |
L4 E | |
L1 A | |
L4 E | |
L5 E | |
L4 E | |
L3 C | |
L5 D | |
L4 B | |
L4 B | |
L4 C | |
L2 B | |
L1 C | |
L1 D | |
L3 C | |
-- -- -- | |
L3 D | |
L3 E | |
L2 D | |
L3 D | |
L5 A | |
L3 A | |
-- -- -- | |
L3 E | |
L5 E | |
L2 A | |
L2 E | |
L1 E | |
-- -- -- | |
-- -- -- | |
L3 E | |
L4 E | |
L3 E | |
L4 E | |
L3 E | |
Abrams & Bayliss LLPLocal | L2 D |
L2 E | |
L1 D | |
-- -- -- | |
L2 E | |
L4 C | |
L2 B | |
L2 E | |
-- -- -- | |
Rogowski LawLocal | L1 C |
L1 C | |
L1 E | |
L4 E | |
L4 E | |
L3 E | |
L3 E | |
James S Green JRLocal | -- -- -- |
L1 C |
No Attorneys